Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Jan / OCTA for Early DR Detection
Research & Innovations

OCTA for Early DR Detection

Evaluating vascular fragmentation and branching pattern features of early diabetic retinopathy

By The Ophthalmologist 1/13/2025 1 min read

Share

Credit: AdobeStock.com

A recent study published in Investigative Ophthalmology & Visual Science has highlighted the potential of optical coherence tomography angiography (OCTA) for detecting early vascular changes in diabetic retinopathy (DR). Researchers introduced six quantitative OCTA metrics to evaluate branching patterns and vascular fragmentation, measuring in both the foveal and parafoveal regions of the retina.

The team analyzed 99 eyes across three groups: healthy controls (HCs), patients with no DR, and patients with mild DR. The OCTA metrics included branch node number (BNN), branch node density (BND), end point density (EPD), fragmented vessel segment count (FVSC), and fragmented vascular length ratio (FVLR).

The results revealed that both BNN and BND were significantly reduced in patients with mild DR, especially in the deep vascular plexus (DVP), reflecting a loss of vascular complexity and early microvascular damage. Interestingly, BNN and BND in the fovea of the DVP could also distinguish preclinical changes in patients with diabetes but no DR.

In contrast, EPD was significantly elevated in the mild DR group, particularly in the DVP, suggesting compacted or shortened vessels due to disease progression. Additionally, both FVSC and FVLR were significantly increased in patients with mild DR, reflecting heightened vessel fragmentation and microvascular disruption. These changes were more prominent in the DVP, where smaller capillaries are more susceptible to damage from hyperglycemia.

The findings underscore the importance of evaluating the DVP layer for early signs of DR, say the authors, as DR exhibits more pronounced microvascular changes than the superficial vascular plexus (SVP). The novel OCTA metrics – particularly BND, EPD, FVSC, and FVLR – demonstrate significant promise for early DR detection, even before clinical manifestations arise. The study advocates incorporating these advanced OCTA parameters into routine diabetic retinopathy screening.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: